Rhythm Pharmaceuticals, Inc. <RYTM.O>: Leerink Partners assumes coverage with outperform rating; target price $133 vs $145
RYTM•Related News
Bally’s secures USD 560 million loan commitments led by WhiteHawk for Bronx project
BALY•
Brazil Potash signs 28-year power supply contract for Autazes project, cuts upfront costs by USD 33 million
GRO•
RGC Resources Inc <RGCO.O>: Huntington Securities initiates coverage with outperform rating; target price $27
RGCO•
New Jersey Resources Corp <NJR.N>: Huntington Securities initiates coverage with outperform rating; target price $68
NJR•
NRx Pharma unit GeNeuro wins European patent for ALS antibody candidate GNK-301
NRXP•